This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
The AMA is imploring physicians to serve as ‘full partners’ with other AI stakeholders throughout the technology’s life cycle in relevantly equipped clinical devices.
The WVU Heart and Vascular Institute is hosting a two-day symposium focused on exploring the benefits and long-term potential of robotic aortic valve replacement. Fans of the procedure say it represents a safe, effective alternative to TAVR and SAVR in patients with severe aortic stenosis.
The Association of Black Cardiologists hopes to improve widespread disparities in care through the use of patient education, free diagnostic heart screenings and other proven methods.
The presentations will cover a variety of topics, including coronary artery disease, semaglutide, artificial intelligence, TAVR, heart failure, PCI and much more. ACC.25 takes place March 29-31 in Chicago.
Meril Life Sciences has been manufacturing its Myval heart valves for years. The devices are approved and available in both India and Europe, but they have not been approved by the FDA.
Integrating AI into the electronic medical record can make patient data more usable and dependable for end-users, according to a review of the relevant scientific literature published this month in the American Journal of Clinical and Medical Research.
It looked like the wildfires in Los Angeles could force STS to cancel its annual meeting, but the group worked with city officials and was able to carry on as planned. STS President Jennifer C. Romano, MD, MS, discussed that difficult decision and previewed the three-day event in a new interview.
When appropriately applied in critical care settings, AI can deliver considerable value to clinical staff, hospital management and local communities. In the process the technology may help resolve persistent staffing shortages.
Maquet Cardiovascular, a subsidiary of Getinge, is recalling two of its endoscopic vessel harvesting devices due to issues with different pieces bending, peeling or detaching during use. Some of the company's other EVH devices were recently involved in a separate recall for similar reasons.